New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 14, 2014
05:52 EDTTSROTESARO price target raised to $51 from $42 at Citigroup
Citigroup raised its price target for TESARO shares to $51 citing the company's expanded immuno-oncology pipeline following its license agreement with AnaptysBio. Citi keeps a Buy rating on the stock, saying shares remain compelling.
News For TSRO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 31, 2015
19:27 EDTTSROTESARO initiated with a Strong Buy at Raymond James
Subscribe for More Information
August 20, 2015
05:48 EDTTSROMizuho keeps TESARO, Verastem, OncoMed as top biotech picks
Subscribe for More Information
August 19, 2015
07:22 EDTTSROCitigroup to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use